Redesigning Follow-Up Pathways: A Practical Guide for NHS Teams

Why This Topic Matters

The landscape of healthcare is continually evolving, driven by an increasing burden of chronic disease, advancements in treatment, and rising patient expectations. Traditional follow-up models, often predicated on routine, fixed-interval appointments, are frequently unsustainable and not always aligned with individual patient needs.

The 'Why' for Redesign:

• Patient-Centred Care: Moving away from a 'one-size-fits-all' approach to care tailored to individual patient needs, preferences, and risk profiles.
• Optimising Capacity: Many clinics have significant proportions of patients who could be safely managed with less frequent in-person reviews, remote monitoring, or self-management support, freeing up valuable clinician time and clinic slots.
• Improving Access: Reduced demand on routine appointments can shorten waiting lists for new patient assessments or those requiring more urgent review.
• Reducing Unwarranted Variation: Standardised, evidence-based pathways can minimise differences in care delivery and outcomes.
• Financial Sustainability: Efficient pathways can lead to cost savings through reduced administrative burden, better resource allocation, and prevention of avoidable complications.
• Staff Wellbeing: Streamlined processes and reduced administrative load can improve staff satisfaction and reduce burnout.

National initiatives, such as the Getting It Right First Time (GIRFT) programme, consistently highlight the potential for improvements in follow-up care across numerous specialties, advocating for patient-initiated follow-up (PIFU) and alternative models of care.

Practical Explanation of Pathway Redesign

Pathway redesign is a systematic process of critically examining existing care delivery, identifying opportunities for improvement, and implementing new, more efficient, and effective models. For follow-up pathways, this often involves:

1. Stratification of Patients: Categorising patients by clinical need, risk of deterioration, and ability to self-manage. This moves away from arbitrary follow-up schedules.
2. Introducing Patient-Initiated Follow-Up (PIFU): Empowering stable patients to initiate contact with the service only when they need it, replacing routine appointments. This is a key recommendation from NHS England and GIRFT.
3. Remote Monitoring and Virtual Clinics: Utilising technology for consultations (e.g., video, telephone) and monitoring (e.g., wearables, apps) to reduce the need for in-person visits.
4. Shared Care Models: Collaborating with primary care or other specialist services for appropriate follow-up, ensuring care is delivered at the most appropriate level.
5. Multi-Disciplinary Team (MDT) Working: Ensuring all relevant healthcare professionals (doctors, nurses, allied health professionals, pharmacists) contribute to the follow-up process according to their expertise.
6. Integrated Digital Solutions: Leveraging electronic patient records, patient portals, and other digital tools to support efficient communication, scheduling, and data collection.

The core principle is to ensure that every follow-up contact adds value and is proportionate to the patient's clinical need and preferences, while maintaining safety and clinical oversight.

Common Pitfalls

Redesigning pathways can be challenging. Awareness of common pitfalls can help teams navigate the process more smoothly:

• Lack of Stakeholder Engagement: Failing to involve patients, clinicians (across all disciplines), administrative staff, and management from the outset can lead to resistance and non-adoption.
• Insufficient Data Analysis: Not thoroughly understanding the current pathway's performance, patient demographics, and demand patterns means solutions may not address the root causes of inefficiency.
• 'Lip Service' to PIFU: Implementing PIFU without robust patient education, clear access routes, and adequate staff training can undermine its effectiveness and patient safety.
• Underestimating Change Management: Overlooking the human element of change – fear, uncertainty, and habit – can derail even well-designed plans. Effective communication and support are vital.
• Poor IT Integration: Digital tools that are cumbersome, not integrated with existing systems, or poorly supported can create more problems than they solve.
• Absence of Evaluation Metrics: Without clear metrics for success and a plan for ongoing monitoring, it's impossible to know if the redesign has achieved its objectives or where further refinements are needed.
• Safety Concerns: Not adequately addressing how patient safety will be maintained, particularly for vulnerable groups or those with fluctuating conditions.
• Lack of 'Golden Thread': Ensuring that the redesign aligns with strategic objectives, both local and national, and clearly demonstrating the link to improved patient care and service delivery.

A Step-by-Step Approach to Follow-Up Pathway Redesign

This framework provides a structured approach, often known as a Quality Improvement (QI) methodology, for pathway redesign.

Step 1: Define the Problem and Set Aims

• Identify the specific pathway: Which clinical area or condition are you focusing on? Start small if needed.
• Gather baseline data: Quantify the problem. How many follow-up appointments? What's the DNA rate? How long are waiting lists? What is the patient experience? (e.g., number of routine follow-up appointments per year, average wait time for a routine appointment, patient satisfaction scores).
• Articulate clear aims: What do you want to achieve? Use SMART (Specific, Measurable, Achievable, Relevant, Time-bound) goals. (e.g., Reduce routine cardiology follow-up appointments by 25% within 12 months, without compromising patient safety, improving patient reported experience measures).

Step 2: Understand the Current Pathway (Process Mapping)

• Map the 'as-is' process: Involve all stakeholders. Visually map every step, decision point, and hand-off in the current pathway. Identify where patients wait, where information is duplicated, and where value is lost.
• Identify pain points and opportunities: Where are the bottlenecks? What frustrates patients or staff? Where is there unwarranted variation?
• Review existing evidence: What do NICE guidelines, Royal College recommendations, or specialist society guidance say about optimal follow-up? Look at examples of best practice from other trusts (e.g., GIRFT reports).

Step 3: Design the 'To-Be' Pathway

• Brainstorm solutions: Based on your understanding and evidence review, generate ideas for a new pathway. Consider patient stratification, PIFU, remote options, and shared care.
• Develop the 'to-be' process map: Outline the ideal future state. How will patients enter, progress, and exit the pathway? Define roles and responsibilities clearly.
• Address potential risks: Conduct a risk assessment (e.g., FMEA - Failure Mode and Effects Analysis) for the new pathway, especially regarding patient safety. How will you monitor high-risk patients? What are the escalation procedures?
• Secure buy-in: Present the proposed pathway to key stakeholders for feedback and secure their commitment.

Step 4: Plan for Implementation

• Develop an action plan: Detail who will do what, by when. What training is required? What IT changes are needed? What patient information resources are essential?
• Identify resources: What staff, equipment, or funding will be required? Is it available or can it be secured?
• Pilot the change (PDSA cycles): Don't roll out large-scale changes immediately. Test the new pathway on a small scale first (Plan-Do-Study-Act cycles). Learn from these small tests and refine the process.
• Communication strategy: How will you inform patients, staff, and referring clinicians about the changes?

Step 5: Implement and Monitor

• Roll out the new pathway: Once pilot testing is successful and refinements are made, implement the pathway more widely.
• Collect data against your aims: Continuously monitor your key metrics (e.g., number of routine appointments, patient satisfaction, safety incidents, staff workload). This is critical for demonstrating impact and identifying areas for further adjustment.
• Establish a review mechanism: Plan regular reviews of the pathway's performance and impact. Is it meeting its objectives? Are there any unintended consequences?

Step 6: Sustain and Spread

• Embed the changes: Make the new pathway standard practice. Update policies, procedures, and training materials.
• Share learning: Disseminate your findings within your department, trust, and wider NHS to encourage adoption of successful models.
• Continuous improvement: Pathway redesign is not a one-off event. It's an ongoing process of monitoring, evaluation, and refinement.

Example in Clinical Practice: Redesigning Oncology Follow-Up

The Problem: A busy oncology department had a large cohort of patients post-treatment for low-risk solid tumours (e.g., early-stage breast cancer, prostate cancer) attending routine face-to-face follow-up appointments for years. This led to long waiting lists, clinic overruns, and patient dissatisfaction due to unnecessary hospital visits.

The Aim: To reduce the number of routine, face-to-face follow-up appointments by 40% for suitable low-risk oncology patients within 18 months, without compromising patient safety, and improving patient experience.

The Approach:

1. Patient Stratification: Working with oncologists, clinical nurse specialists, and patients, clear criteria were developed to identify patients suitable for an alternative follow-up model (e.g., stable disease for >2 years, good performance status, no concerning symptoms, access to digital communication).
2. Implementation of PIFU: For eligible patients, a PIFU model was introduced. Patients received a comprehensive end-of-treatment summary, a patient information leaflet explaining PIFU, and clear contact details for a dedicated 'hotline' or CNS if symptoms developed or they had concerns.
3. Remote Monitoring & Education: Patients were encouraged to self-monitor and were provided with symptom checkers and links to trusted online resources. A small number also used secure patient portals for submitting PROMs (Patient-Reported Outcome Measures).
4. Clinical Nurse Specialist (CNS) Role Expansion: The CNS team's role evolved to manage the PIFU hotline, provide specialist advice, and coordinate care for those who initiated contact.
5. Pilot and Scale-Up: The new pathway was piloted with a small group of breast cancer patients, refining the patient information and contact protocols based on their feedback and staff experience. Following successful pilots, it was incrementally rolled out to other suitable tumour groups.
6. Monitoring and Evaluation: Data was collected on the reduction in routine appointments, patient initiation rates, time to contact resolution, and patient/staff feedback. Importantly, adverse event rates were closely monitored and compared to baseline.

Outcome: The department achieved a 35% reduction in routine follow-up appointments for the targeted patient group within 18 months. Patient feedback was largely positive, appreciating the reduced need for hospital visits and the empowerment of self-management. Clinicians reported a more focused workload, allowing more time for complex cases. The safety profile remained comparable to the traditional pathway, demonstrating that effective redesign can deliver both efficiency and patient-centred care.

How Lazomis Can Help

Lazomis provides a structured approach and practical tools to support your follow-up pathway redesign efforts:

• Project Management & Collaboration: Use Lazomis to set up your redesign project, define aims, assign tasks to your team, and track progress, ensuring all stakeholders are kept informed.
• Data Collection & Analysis: Leverage Lazomis data collection tools and dashboards to capture baseline metrics, monitor the impact of your changes, and visualise trends over time. This helps you demonstrate the impact of your redesigned pathway.
• Process Mapping & Flowcharts: Utilise embedded tools to create clear, visual representations of your 'as-is' and 'to-be' pathways, facilitating identification of inefficiencies and communication of the new process.
• Reporting & Dissemination: Generate concise reports on your project's progress and outcomes, making it easier to share your learning and advocate for wider adoption of successful redesigns.

This resource supports, but does not replace, clinical judgement. Local policy, formulary and specialist advice should be followed. Ensure all redesign activities are approved through local governance processes, including clinical safety and information governance reviews.

Key Takeaways

• Follow-up pathway redesign is essential for patient-centred care, capacity optimisation, and service sustainability.
• Effective redesign moves beyond routine appointments to embrace patient stratification, PIFU, and remote care models.
• Thorough stakeholder engagement, robust data analysis, and effective change management are critical for success.
• Pilot testing (PDSA cycles) allows for refinement of new pathways before wider implementation.
• Continuous monitoring and evaluation are necessary to ensure safety, efficacy, and sustained improvements.
• Lazomis tools can streamline the project management, data analysis, and reporting aspects of pathway redesign.